Approximately 900 children are newly infected with HIV every day, and nearly all of these children acquire HIV from their mothers during pregnancy, childbirth or breastfeeding. However, effective, inexpensive and safe medical interventions that prevent HIV transmission to infants and protect the health of their mothers are available, even in settings where resources are constrained.

Johnson & Johnson envisions a world in which no baby is born with HIV and every mother has the opportunity to help her baby thrive. Preventing maternal-to-child transmission of HIV is thus a cornerstone of our philanthropic commitment to reduce the burden of HIV and AIDS on women and their families.

For almost a decade, Johnson & Johnson has pursued a comprehensive strategy to end this unnecessary global health tragedy. From 2003-2001, J&J has committed $20 million to effective partnerships, including our long collaborations with mothers2mothers (m2m) and the Elizabeth Glaser Pediatric AIDS Fo